Rubicon Genomics and Abbott Molecular Sign Agreement to Co-Develop Simple Non-Invasive Cancer Diagnostic Tests
News Nov 01, 2005
Rubicon Genomics, Inc., have announced a multi-year Research and Option Agreement with Abbott Molecular, a division of Abbott, to develop and commercialize its MethylPlex™ methylation detection technology for diagnosis and prognosis of cancer.
MethylPlex™ is designed to be a very sensitive and simple method to detect the patterns of abnormal DNA methylation arising in serum and urine during tumor formation and progression.
Methylation is a natural process that occurs when a methyl group is introduced into one of DNA's four bases, cytosine. The presence of methylation is responsible for controlling the activity of genes by turning them off, like a switch, when not needed.
By measuring the differences in the methylation patterns between healthy and diseased tissue, a change in gene activity that could trigger diseases such as cancer can be detected.
The patient tests will employ proprietary Rubicon methylation markers in conjunction with a radically-simplified method to detect those markers, which overcomes the barriers of sensitivity, cost and time that have hampered the implementation of DNA methylation screening up to this point.
The primary focus of the collaboration will be non-invasive detection of prostate and bladder cancer. "We believe that DNA methylation is the most sensitive and specific indication of early cancer detection and prognosis," said Fred Beyerlein, President and CEO of Rubicon Genomics.
"We are looking forward to working with Abbott, a recognized leader in the field of cancer diagnostics. This is a great match of innovative technology and in-depth disease and market expertise."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018